Retia Medical Stock

Retia is medical device company that develops and sells software and hardware for patient monitoring.

Sign up today and learn more about Retia Medical Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Retia Medical Stock

Retia Medical develops monitors for high-risk patients. Retia’s first product monitors cardiac output, a critical health metric that indicates the flow rate of blood pumped by the heart. The initial target market for this technology is the ICU and perating rooms. It is potentially extendable for use in emergency rooms or at home. Based in East Lansing, MI, Retia’s technology was exclusively licensed from MSU and validated through extensive tests in animals and humans. With the support of the Pritzker/Vlock family office and a strong advisory board composed of industry and clinical experts, Retia will seek FDA approval and launch this product, which will help revolutionize the care of our most at-risk patients.

Funding History

August 2012$7.0M
July 2022$15.0M

Management

Board of Directors

Michael Tal

Co-Founder

Ramakrishna Mukkamala

Research Intern

Tanvi Gangal

Chief Financial Officer

Jon Fish

Co-Founder, CEO & Board of Directors

Marc Zemel

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo